Published in Antimicrob Agents Chemother on August 01, 1979
Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. Antimicrob Agents Chemother (2006) 0.96
Phenothiazine compounds inhibit in vitro growth of pathogenic free-living amoebae. Antimicrob Agents Chemother (1984) 0.95
Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. Antimicrob Agents Chemother (2003) 0.89
Naegleria fowleri: Pathogenesis, Diagnosis, and Treatment Options. Antimicrob Agents Chemother (2015) 0.75
Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism). Proc Natl Acad Sci U S A (1972) 4.09
Primary amoebic meningo-encephalitis. An appraisal of present knowledge. Trans R Soc Trop Med Hyg (1972) 3.68
Potentiation of the antifungal effects of antibiotics by amphotericin B. Antimicrob Agents Chemother (1972) 2.24
Sensitivity to amphotericin B of a Naegleria sp. isolated from a case of primary amoebic meningoencephalitis. J Clin Pathol (1969) 2.12
Primary amoebic meningoencephalitis in Britain. Br Med J (1970) 2.10
Synergism of amphotericin B and 5-fluorocytosine for candida species. J Infect Dis (1975) 1.61
Light and electron microsopic observations on the pathogenesis of Naegleria fowleri in mouse brain and tissue culture. J Protozool (1974) 1.60
Small, free-living amebas: cultivation, quantitation, identification, classification, pathogenesis, and resistance. Curr Top Comp Pathobiol (1971) 1.60
Synergistic action of amphotericin B and rifampin on Candida albicans. Am Rev Respir Dis (1974) 1.26
Changes in the virulence of Naegleria fowleri maintained in vitro. J Parasitol (1977) 1.25
In vitro effects of amphotericin B on growth and ultrastructure of the amoeboflagellates Naegleria gruberi and Naegleria fowleri. Antimicrob Agents Chemother (1975) 1.25
Combined amphotericin B-tetracycline therapy for experimental coccidioidomycosis. Antimicrob Agents Chemother (1974) 1.23
Antifungal activity of four tetracycline analogues against Candida albicans in vitro: potentiation by amphotericin B. J Infect Dis (1977) 1.18
Experimental infections with pathogenic free-living amebae in laboratory primate hosts: I (A) A study on susceptibility to Naegleria fowleri. J Parasitol (1975) 1.03
In vitro susceptibility of pathogenic Naegleria and Acanthamoeba speicies to a variety of therapeutic agents. Antimicrob Agents Chemother (1976) 0.99
Letter: Primary amoebic meningoencephalitis. Lancet (1974) 0.98
Synergism between tetracycline and amphotericin B in experimental amoebic meningoencephalitis. Med J Aust (1978) 0.96
Growth inhibition of Naegleria fowleri by tetracycline, rifamycin, and miconazole. Lancet (1977) 0.87
RELEASE OF INTRACELLULAR CONSTITUENTS OF CANDIDA ALBICANS IN PRESENCE OF POLYENE ANTIBIOTICS. Ann Biochem Exp Med (1963) 0.82
Metachromatic agar-diffusion methods for detecting staphylococcal nuclease activity. Appl Microbiol (1971) 10.60
Obfuscation of the activity of antifungal antimicrobics by culture media. J Infect Dis (1972) 7.47
Nuclease production and lysostaphin susceptibility of Staphylococcus aureus and other catalase-positive cocci. Appl Microbiol (1971) 3.40
Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med (2000) 3.12
Role of pili in adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells. Infect Immun (1988) 2.63
Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol (1999) 2.46
Gentamicin therapy in renal failure: a nomogram for dosage. Ann Intern Med (1972) 2.43
Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester. J Infect Dis (1976) 2.31
Interaction of Shc with the zeta chain of the T cell receptor upon T cell activation. Science (1993) 2.25
Diagnostic usefulness and safety of transtracheal aspiration. N Engl J Med (1967) 2.23
Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites. N Engl J Med (1989) 2.23
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study. JAMA (1986) 2.20
An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation--a VA cooperative study. Stat Med (1996) 2.14
Susceptibility of three groups of Staphylococcus aureus to newer antimicrobial agents. Antimicrob Agents Chemother (1977) 2.09
Use of hyaluronidase as an adjuvant to ropivacaine to reduce axillary brachial plexus block onset time: a prospective, randomised controlled study. Anaesthesia (2014) 1.99
Aberrant methylation of donor genome in cloned bovine embryos. Nat Genet (2001) 1.94
Problems in the diagnosis and treatment of systemic candidiasis. J Infect Dis (1972) 1.83
Transcriptional repression, apoptosis, human disease and the functional evolution of the nuclear lamina. Trends Biochem Sci (2001) 1.82
Miconazole therapy for coccidioidomycosis. JAMA (1974) 1.81
Penetration of antimicrobial agents into bronchial secretions. Am J Med (1975) 1.74
Effect of epidural anesthesia and analgesia on perioperative outcome: a randomized, controlled Veterans Affairs cooperative study. Ann Surg (2001) 1.69
Structure and function of orthotopic small bowel allografts in rats treated with cyclosporine. Am J Surg (1986) 1.69
BAF is required for emerin assembly into the reforming nuclear envelope. J Cell Sci (2001) 1.67
Transformation of Mycoplasma pneumoniae with Tn4001 by electroporation. Plasmid (1993) 1.66
Comparison of laparoscopic versus open repair of paraesophageal hernia. Am J Surg (1998) 1.62
Myelomatous effusion with poor response to chemotherapy. J Korean Med Sci (2000) 1.60
Characterization of the Pseudomonas aeruginosa pilus adhesin: confirmation that the pilin structural protein subunit contains a human epithelial cell-binding domain. Infect Immun (1989) 1.58
Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol (1990) 1.57
Prediction of antimeningococcic chemoprophylactic efficacy. J Infect Dis (1971) 1.55
Inhibition of pilus-mediated adhesion of Pseudomonas aeruginosa to human buccal epithelial cells by monoclonal antibodies directed against pili. Infect Immun (1990) 1.54
Free-flap reconstruction of large defects of the scalp and calvarium. Plast Reconstr Surg (1989) 1.54
LAP2 binds to BAF.DNA complexes: requirement for the LEM domain and modulation by variable regions. EMBO J (2001) 1.53
Premarital sexual intercourse among adolescents in Malaysia: a cross-sectional Malaysian school survey. Singapore Med J (2006) 1.52
Comparison of amphotericin B and amphotericin B methyl ester: efficacy in murine coccidioidomycosis and toxicity. J Infect Dis (1976) 1.52
Portal versus caval venous drainage of small bowel allografts: technical and metabolic consequences. Surgery (1986) 1.50
Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole. J Infect Dis (1975) 1.50
Effect of buffers on testing of Candida species susceptibility to flucytosine. J Clin Microbiol (1987) 1.44
The pili of Pseudomonas aeruginosa strains PAK and PAO bind specifically to the carbohydrate sequence beta GalNAc(1-4)beta Gal found in glycosphingolipids asialo-GM1 and asialo-GM2. Mol Microbiol (1994) 1.43
Lethal attribute of serine protease secreted by Vibrio alginolyticus strains in kuruma prawn Penaeus japonicus. Z Naturforsch C (2000) 1.41
Menstruation among adolescent girls in Malaysia: a cross-sectional school survey. Singapore Med J (2006) 1.39
Chemotherapy of systemic fungal diseases. Annu Rev Pharmacol Toxicol (1978) 1.39
Development of resistance to 5-fluorocytosine in Candida parapsilosis during therapy. J Infect Dis (1974) 1.38
Merocel nasal packing with airway: a method to help secure full-thickness skin grafts on the nasal tip. Br J Dermatol (2009) 1.38
Experimental and clinical aspects of resistance determinants. Mode of resistance against beta-lactam antibiotics in staphylococci. Ann N Y Acad Sci (1971) 1.36
Gentamicin versus staphylococcus aureus. J Infect Dis (1969) 1.36
Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res (2001) 1.36
Disk agar diffusion susceptibility testing of yeasts. Antimicrob Agents Chemother (1978) 1.35
Thermonuclease seroinhibition test for distinguishing Staphylococcus aureus from other coagulase-positive staphylococci. J Clin Microbiol (1979) 1.32
LPS-induced muscularis macrophage nitric oxide suppresses rat jejunal circular muscle activity. Am J Physiol (1999) 1.32
Synthetic medium for susceptibility testing. Antimicrob Agents Chemother (Bethesda) (1970) 1.31
Lamins and disease: insights into nuclear infrastructure. Cell (2001) 1.30
Quantitative analysis of bacterial toxin affinity and specificity for glycolipid receptors by surface plasmon resonance. J Biol Chem (1997) 1.30
Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole. J Clin Microbiol (1986) 1.30
Lipopolysaccharide activates the muscularis macrophage network and suppresses circular smooth muscle activity. Am J Physiol (1997) 1.29
An unusual outbreak of windborne coccidioidomycosis. N Engl J Med (1979) 1.27
Changes in the virulence of Naegleria fowleri maintained in vitro. J Parasitol (1977) 1.25
Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8. Oncogene (1997) 1.23
Bacteriology of the lower respiratory tract as determined by fiber-optic bronchoscopy and transtracheal aspiration. J Infect Dis (1976) 1.23
Factors affecting the distribution of hydrocarbon contaminants and hydrogeochemical parameters in a shallow sand aquifer. J Contam Hydrol (2001) 1.21
Metachromatic agar-diffusion microslide technique for detecting staphylococcal nuclease in foods. Appl Microbiol (1972) 1.20
Nocardial brain abscess cured with cycloserine and sulfonamides. Am J Med Sci (1968) 1.20
Laparotomy for fulminant pseudomembranous colitis. Arch Surg (1992) 1.19
Heat induced aggregation of the sodium dodecyl sulfate-solubilized main intrinsic polypeptide isolated from bovine lens plasma membrane. Biochem Biophys Res Commun (1978) 1.18
Occurrence of protein A in Staphylococcus aureus and closely related Staphylococcus species. J Clin Microbiol (1979) 1.18
Effect of tetracycline, polymyxin B, and rifampin on phagocytosis. Clin Pharmacol Ther (1970) 1.17
Stability of four antifungal antimicrobics in vitro. J Infect Dis (1978) 1.17
Transcriptional analysis of the hmw gene cluster of Mycoplasma pneumoniae. J Bacteriol (1999) 1.16
Distribution of doubly radiolabelled amphotericin B methyl ester and amphotericin B in the non-human primate, Macaca mulatta. J Antimicrob Chemother (1980) 1.16
Nucleotide sequence analysis reveals novel features of the phase-variable cytadherence accessory protein HMW3 of Mycoplasma pneumoniae. Infect Immun (1992) 1.16
Prognosis of mechanically ventilated patients. West J Med (1993) 1.15
Comparative pharmacology of amphotericin B and amphotericin B methyl ester in the non-human primate, Macacca mulatta. Antimicrob Agents Chemother (1977) 1.15
Pathogenesis of pancreatic sepsis. Am J Surg (1993) 1.14
Filarial antibodies and eosinophilia in human subjects in an endemic area. Trans R Soc Trop Med Hyg (1969) 1.13
A potential diagnostic reagent for bovine cysticercosis. J Parasitol (1985) 1.11
Parasitic infections among traveling students. West J Med (1976) 1.11
Convenient assay for staphylococcal nuclease by the metachromatic well-agar-diffusion technique. Appl Microbiol (1972) 1.10
Treatment of open fractures: a prospective study. J Trauma (1983) 1.10
Effect of basic fibroblast growth factor. An in vitro study of tendon healing. Clin Orthop Relat Res (1997) 1.10
Typical demethylation events in cloned pig embryos. Clues on species-specific differences in epigenetic reprogramming of a cloned donor genome. J Biol Chem (2001) 1.10
Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections. Ann Intern Med (1977) 1.08
Purification and characterization of a cysteine protease produced by pathogenic luminous Vibrio harveyi. Curr Microbiol (1997) 1.06
Domenico solution--is it valid? Ground Water (2007) 1.06
Susceptibility of "methicillin"-resistant Staphylococcus aureus to 12 antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1969) 1.05
Evidence that aspartic acid 301 is a critical substrate-contact residue in the active site of cytochrome P450 2D6. J Biol Chem (1995) 1.05
Effect of nitrogen dioxide on pulmonary bacterial defense mechanisms. Arch Environ Health (1973) 1.05
Small bowel transplantation and chronic rejection alter rat intestinal smooth muscle structure and function. Surgery (1993) 1.04
Cloning and analysis of the gene encoding the cytadherence phase-variable protein HMW3 from Mycoplasma pneumoniae. Gene (1991) 1.04
Fabrication of ultralow-loss Si/SiO(2) waveguides by roughness reduction. Opt Lett (2001) 1.03
Experimental infections with pathogenic free-living amebae in laboratory primate hosts: I (A) A study on susceptibility to Naegleria fowleri. J Parasitol (1975) 1.03
Some properties of lens plasma membrane polypeptides isolated from normal human lenses. Exp Eye Res (1979) 1.03
Infective endocarditis caused by Streptococcus bovis resistant to the lethal effect of penicillin G. Arch Intern Med (1978) 1.03
Tolerance of staphylococcal thermonuclease to stress. Appl Microbiol (1972) 1.03
Fimbria-mediated adherence of Candida albicans to glycosphingolipid receptors on human buccal epithelial cells. Infect Immun (1994) 1.03
Prevalence of nifedipine-induced gingival hyperplasia. J Periodontol (1995) 1.02
Functional impairment of enteric smooth muscle and nerves caused by chronic intestinal allograft rejection regresses after FK506 rescue. Transplantation (1995) 1.02